1. Home
  2. UFPI vs GPCR Comparison

UFPI vs GPCR Comparison

Compare UFPI & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Industries Inc.

UFPI

UFP Industries Inc.

N/A

Current Price

$89.71

Market Cap

5.3B

ML Signal

N/A

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

N/A

Current Price

$55.05

Market Cap

6.3B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
UFPI
GPCR
Founded
1955
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Forest Products
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
6.3B
IPO Year
2011
2023

Fundamental Metrics

Financial Performance
Metric
UFPI
GPCR
Price
$89.71
$55.05
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$102.50
$104.64
AVG Volume (30 Days)
267.7K
696.8K
Earning Date
05-27-2026
05-29-2026
Dividend Yield
1.55%
N/A
EPS Growth
N/A
N/A
EPS
5.00
N/A
Revenue
$3,941,182,000.00
N/A
Revenue This Year
$2.42
N/A
Revenue Next Year
$5.92
N/A
P/E Ratio
$18.11
N/A
Revenue Growth
21.62
N/A
52 Week Low
$87.11
$13.24
52 Week High
$118.00
$94.90

Technical Indicators

Market Signals
Indicator
UFPI
GPCR
Relative Strength Index (RSI) 21.40 27.64
Support Level $89.23 $18.36
Resistance Level $94.30 $93.91
Average True Range (ATR) 3.42 2.98
MACD -1.87 -0.71
Stochastic Oscillator 3.07 0.71

Price Performance

Historical Comparison
UFPI
GPCR

About UFPI UFP Industries Inc.

UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction. Its business segments consist of UFP Retail Solutions, UFP Packaging, UFP Construction, All other and Corporate. It describes itself as an innovation company, a logistics company, a design company, an engineering and value-added product and solutions company.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: